They serve as microscopic drug capsules that are less than a thousandth of a millimeter in diameter. Among other things, they are used in current vaccines against the Corona virus to effectively deliver active ingredients to where they are actually needed. In most cases, the capsules dock onto cells, are enveloped by them, and are absorbed into them. Inside the cell, chemical processes can then open the capsules, releasing the active ingredient.
However, this idealized process usually does not take place: As it travels through the bloodstream, blood proteins accumulate on the surface of the nanotransporter. These also find their way into the cell. For a long time, it was an unresolved question whether this process impairs the release of the active ingredient.
Scientists working with Ingo Lieberwirth, group leader in Katharina Landfester's department, have now addressed this question. They have labelled a nanoparticle and blood proteins with different fluorescent dyes. As a result, both glow with different colours when viewed through a high-resolution light microscope. At the same time, the researchers were able to observe the process in parallel and at higher resolution using an electron microscope.
By combining both methods, the scientists were able to observe that the cell initially absorbs the composite of nanoparticles and blood proteins. In the cell, they now observed something surprising: The protein coating detaches from the nanoparticle and releases it. After some time, proteins and particles are present separately in the cell.
"We therefore assume that the drug release in the cell is not disturbed by the protein coating," says Ingo Lieberwirth. "However, it is now important to find out how exactly the process takes place inside the cell."
COMPAMED-tradefair.com; Source: Max Planck Institute for Polymer Research
